IL10 and Hyperglycemia: Another novel and intriguing possibility that we have presented here is a potential “resistance” to IL-10’s classical anti-inflammatory actions, which may provide a mechanistic link between hyperglycemia/diabetes and severe COVID-19-related outcomes (Figure 1B).